首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   159篇
  免费   7篇
  国内免费   1篇
妇产科学   1篇
基础医学   6篇
临床医学   6篇
内科学   10篇
神经病学   4篇
特种医学   11篇
外科学   7篇
综合类   8篇
预防医学   10篇
药学   1篇
中国医学   2篇
肿瘤学   101篇
  2023年   26篇
  2022年   26篇
  2021年   19篇
  2020年   22篇
  2019年   6篇
  2018年   4篇
  2017年   9篇
  2016年   8篇
  2015年   7篇
  2014年   5篇
  2013年   4篇
  2012年   6篇
  2011年   4篇
  2010年   6篇
  2009年   3篇
  2008年   2篇
  2007年   1篇
  2006年   2篇
  2005年   1篇
  2004年   1篇
  1999年   1篇
  1996年   1篇
  1994年   1篇
  1993年   1篇
  1988年   1篇
排序方式: 共有167条查询结果,搜索用时 15 毫秒
41.
鼻咽癌患者根治性常规放疗后335例生存分析   总被引:2,自引:1,他引:1  
目的总结鼻咽癌患者根治性常规放疗后长期生存情况。方法经病理证实为鼻咽癌、行连续根治性常规放疗的初治患者335例,男女比例为2.28:1,发病中位年龄47岁(15~77岁);Ⅰ,Ⅱ,Ⅲ,Ⅳa及Ⅳb期分别占3.9%,19.4%,35.2%,40.0%及1.5%。直线加速器、低熔点铅挡、常规分割外照射.鼻咽原发灶中位剂量72Gy,每次1.8~2.0Gy,面颈联合野+面颈联合缩野+耳前野三阶段照射。57.0%的患者接受顺铂+氟尿嘧啶1~2周期的诱导化疗和/或1~5周期的辅助化疗。结果随访率92.1%.中位随访时间55月(1~104月)。全组5年总生存率、无进展生存率、无复发生存率、无远处转移生存率、无进展率、区域控制率及无远处转移率分别为71.4%,61.3%,66.2%,65.9%,70.2%,86.6%及79.6%;Ⅰ,Ⅱ,Ⅲ,Ⅳa及Ⅳb期患者5年生存率分别为100.0%,86.2%.75.7%,57.4%及7.0%。发生率较高的晚期损伤依次为口干燥症、颈部纤维化、张口受限、听力缺失、龋齿与牙脱落、吞咽困难、声音改变。放射性脑病、后组脑神经损伤的独立影响因素分别为原发灶剂量(P=0.032)、T分期(P=0.015)。结论对于原发灶剂量大、T分期较晚者应注意防治放射性脑病。  相似文献   
42.
ERBB2 (HER2/Neu) gene amplification and overexpression is associated with increased risk of metastases and shorter survival in breast cancer. Tyrosine 1248 is a major phosphorylation site of ERBB2 and reflects the activation status of the receptor. The aim of this study was to investigate the relationships between quantitative levels of pY1248-ERBB2 (p-ERBB2) and the expression of epidermal growth factor receptor (EGFR)-family members, and whether p-ERBB2 could provide additional prognostic value compared with established prognostic markers. For this purpose we developed a highly sensitive chemiluminescence-linked immunoassay (CLISA) and detected p-ERBB2 levels in 70 primary breast cancer biopsies. Phosphorylated ERBB2 correlated with EGFR and ERBB2, and inversely with oestrogen receptor (ER), progesterone receptor (PgR) and ERBB4 expression levels. Additionally, p-ERBB2 was associated with poor clinical outcome in univariate and multivariate Cox regression analysis. Further studies are needed to evaluate the predictive value of p-ERBB2.  相似文献   
43.
44.
《Clinical breast cancer》2022,22(4):e480-e487
AimTo report toxicity of hypofractionated whole-breast radiotherapy in a large cohort of early-stage breast cancer (BCaients.Materials and methodsFrom 02/2009-05/2017, 1325 consecutive BCa patients were treated with 40.05 Gy/15 fractions, without boost. Median age was 62 (IQR:51.1-70.5) years. Chemotherapy was prescribed for 28% of patients, hormonal therapy for 80.3%, monoclonal antibodies for 8.2%.ResultsMedian follow-up was 72.4 (IQR: 44.6-104.1) months. Acute RTOG toxicity was: 69.8% Grade (G) 1, 14.3% G2 and 1.7% G3. Late SOMA-LENT toxicities were: edema-hyperpigmentation (E-H): G1 28.67%, G2 4.41%, G3 0.15%; fibrosis-atrophy-telangiectasia-pain (F-A-T-P): G1 14.6%, G2 3.2%, G3 0.8%, G4 0.1%. Median time to first occurrence was 6 and 18 months, respectively. Aesthetic result after surgery was excellent in 28.7%, good in 41.5%, acceptable in 20.3% and poor in 9.5% of patients. Change in breast appearance after radiotherapy was mild in 6.9%, moderate in 2.3% and marked in 1.3% of patients. Concomitant chemotherapy, obesity, smoking, use of bolus and planning target volume (PTV) were associated with higher acute toxicity. Patients ≥55 years old were less likely to experience acute toxicity. PTV and acute G2 toxicity were associated with ≥G2 E-H. PTV, concomitant chemotherapy, hypertension and ≥G2 acute toxicity were associated with increased risk of F-A-T-P.ConclusionHypofractionated whole-breast radiotherapy without boost demonstrated mild acute and late toxicity in a large cohort of consecutive patients. Moderate and marked changes in breast appearance were registered for 3.6% of patients and occurred between 18 to 42 months.  相似文献   
45.
PurposeTo evaluate the long-term treatment outcome in patients with recurrent nasopharyngeal carcinoma (NPC) treated with salvage intensity modulated radiotherapy (IMRT).Materials and methodsOne hundred and fifty one previously irradiation NPC patients with recurrent disease and re-irradiated by IMRT between 2001 and 2006 had been reviewed. The disease was re-stage I in 7, re-stage II in 21, re-stage III in 50 and re-stage IV in 73. Thirty-seven patients received concurrent chemotherapy, 39 had induction chemotherapy and 75 had radiotherapy alone.ResultsAll patients completed the planned IMRT. The median volume of the recurrent gross target volume of nasopharynx (rGTVnx) was 42.2 cm3 (range 1.5–146.3 cm3). The median mean re-irradiation dose to the rGTVnx was 70.4 Gy (range 62.1–77.6 Gy). The median follow-up time after re-irradiation was 40.0 months (range 1.9–116.9 month). The 5-year local control rate (LCR) and overall survival rate (OS) for re-stage I, II, III, IV were 80.0%, 85.0%, 80.0%, 78.7% and 71.4%, 62.9%, 35.5%, 30.2%, respectively. Multivariate analysis indicated that rT classification (hazard ratio (HR), 2.02; 95% confidence interval (CI), 1.03–3.97; P = 0.04) and the volume of rGTVnx (HR, 2.05; 95% CI, 1.31–3.22; P < 0.01) were independent predictors for OS. Patients (39.0%) with re-stage III or IV disease experienced Grade 3 or 4 late toxicities.ConclusionRe-irradiation by IMRT for recurrent NPC resulted in encouraging local control. The clinical outcome for patients with early re-stage diseases was satisfactory. Further investigations, focus on optimising radiation dose and establishing effective treatment strategies, are warranted for advanced recurrent disease in order to improve overall survival and minimise late toxicity.  相似文献   
46.
47.
《Clinical breast cancer》2022,22(1):e37-e47
IntroductionLymphedema of the upper extremity is one of the most feared complications following breast cancer treatment. Lymphofluoroscopy is a sensitive instrument for detection of lymphedema and visualization of superficial lymphatic transport, thus suitable for early detection. Early detection of lymphedema is important as it can prevent lymphedema to progress into more severe stages and minimalize impact on quality of life and medical costs.ObjectiveTo determine agreement between the presence of early disturbance of the lymphatic transport and outcome of clinical measurement tools evaluating the development of lymphedema.MethodsA prospective study was conducted in 128 breast cancer patients scheduled for breast cancer surgery. Patients were evaluated before surgery and 1, 3-, 6-, 9-, and 12-months’ post-surgery. Cohen's Kappa was used to determine agreement between presence of early disturbance in lymphatic transport and presence of pitting/increased skinfold thickness/increased Percentage Water Content ratio (PWC)/increased arm-hand volume (circumference measures and water displacement).ResultsFor pitting status (Kappa 0.23), for skinfold thickness (Kappa 0.29) and the PWC ratio (Kappa 0.21) a minimal agreement was found. The circumference measurement had a minimal agreement for 5% volume difference (Kappa 0.22) and no agreement for 3% volume difference (Kappa 0.19). Sensitivity was weak for all clinical assessments. The specificity was excellent for pitting status, skinfold thickness, PWC ratio, and for 5% volume difference. For 3% a high specificity was found.ConclusionThe clinical tools assessed in this study were not able to predict an early disturbance of the lymphatic transport seen on lymphofluoroscopy.  相似文献   
48.
Zou  Kang  Chen  Wenbo  Dai  Jun  Mo  Pingli  Yu  Chundong  Xu  Jianming  Wu  Sangang  Zhuo  Rengong  Su  Guoqiang 《Inflammation》2021,44(3):1145-1159
Inflammation - Inflammation theory has suggested that the pathogenesis of postoperative ileus (POI) involves the steroid receptor coactivator-3 (SRC-3). Therefore, we investigated the role of SRC-3...  相似文献   
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号